CLOT RETRIEVAL DEVICES AND THERAPEUTIC USE THEREOF
The present invention relates to improved clot retrieval devices, wherein at least the part of the device intended to be in contact with a clot is coated with at least one chromatin binding agent selected from the group consisting of digoxigenin, a digoxigenin derivative, distamycin and a distamycin derivative. The present invention also relates to a method of producing said improved clot retrieval device. The present invention also relates to a method of prevention and/or treatment of stroke in a subject, comprising removing at least one clot using the clot retrieval device coated with said least one chromatin binding agent.
1 . A clot retrieval device, wherein at least the part of said device intended to be in contact with a clot, comprising a coating comprising at least one chromatin binding agent, wherein said chromatin binding agent is selected from the group consisting of digoxigenin, a digoxigenin derivative, distamycin and a distamycin derivative.
2 . The clot retrieval device according to claim 1 , wherein said clot retrieval device is a stent retriever.
3 . The clot retrieval device according to claim 1 , wherein said chromatin binding agent is coated on the part of the device intended to be in contact with a clot via at least one coating agent.
4 . The clot retrieval device according to claim 3 , wherein said coating agent is PDA or PDA-PEG bis amine.
5 . The clot retrieval device according to claim 3 , wherein at least the part of said device intended to be in contact with a clot is coated with at least one coating agent and said chromatin binding agent is linked to said coating agent.
6 . The clot retrieval device according to claim 1 , wherein the digoxigenin derivative is a compound of the following formula (III)
wherein L is a linker comprising at least one group selected from the group consisting of an amino, ester, amido, carboxy and hydroxyl group.
7 . The clot retrieval device according to claim 1 , wherein the digoxigenin derivative is digoxigenin NHS ester and/or the distamycin derivative is distamycin azide.
8 . The clot retrieval device according to claim 3 , wherein (i) the chromatin binding agent is digoxigenin NHS ester and the coating agent is PDA PEG bis-amine or (ii) the chromatin binding agent is distamycin azide and the coating agent is PDA.
9 . A method for producing a clot retrieval device according to claim 1 , wherein said method comprises:
a) coating at least the part of the device intended to be in contact with a clot with at least one coating agent, and
b) contacting the part of the device coated with at least one coating agent obtained in step a) with at least one chromatin binding agent.
10 . The method according to claim 9 , wherein step a) comprises contacting at least the part of the device intended to be in contact with a clot with a solution comprising dopamine and, optionally, PEG bis-amine.
11 . A method for removing a clot in a subject, wherein said method comprises removing said clot with a clot retrieval device according to claim 1 or obtained by the method according to claim 9 .
12 . A method for preventing and/or treating stroke in a patient in need thereof, wherein said method comprises removing at least one clot with a clot retrieval device according to claim 1 or obtained by the method according to claim 9 .